Home » Topics » BioWorld Science

BioWorld Science
RSS

RP-7214: a novel DHODH inhibitor with oral activity in preclinical AML models

Nov. 4, 2019

VCP inhibitors patented by University of Pittsburgh

Nov. 4, 2019

HIV replication inhibitors detailed in ViiV Healthcare patent

Nov. 4, 2019

Erytech announces new milestones in TRYbeCA1 phase III study of eryaspase

Nov. 4, 2019

Enanta Pharmaceuticals identifies compounds for RSV infections

Nov. 4, 2019

University of Illinois discloses FOXM1 inhibitors

Nov. 4, 2019

Oligomannate approved in China for mild to moderate AD

Nov. 4, 2019

Neuropore Therapies divulges PIK3C3 inhibitors

Nov. 4, 2019

Promentis Pharmaceuticals announces update on phase II development of SXC-2023

Nov. 4, 2019

OB-002 significantly reduces both primary and metastatic breast cancer in vivo

Nov. 4, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...